Mok, T., Wu, Y. L., Lee, J. S., Yu, C. J., Sriuranpong, V., Sandoval-Tan, J., . . . Wu, L. (2018). Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy.
Chicago Style CitationMok, Tony, et al. Detection and Dynamic Changes of EGFR Mutations From Circulating Tumor DNA As a Predictor of Survival Outcomes in NSCLC Patients Treated With First-line Intercalated Erlotinib and Chemotherapy. 2018.
MLA引文Mok, Tony, et al. Detection and Dynamic Changes of EGFR Mutations From Circulating Tumor DNA As a Predictor of Survival Outcomes in NSCLC Patients Treated With First-line Intercalated Erlotinib and Chemotherapy. 2018.